SEC Form D · Amendment · filed January 12, 2023
Transposon Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Eckard R. Weber, Md · San Diego, CAExec · DirectorEmi Quadri · Toronto, Ontario, CanadaDirectorHayfin Capital Management LLP · London, United KingdomDirectorKarl Sowa · Dallas, TXDirectorJohn R. Pacifico · San Diego, CADirectorBrian T. Slingsby, Md, Phd, Mph · San Diego, CADirectorJames Babcock · New York, NYDirectorPaul Cho · Los Angeles, CAExecBruce Clarke · Dallas, TXDirectorBrock F. Smith · Boca Raton, FLDirectorCharlotte Gummesson · Toronto, Ontario, CanadaDirectorBrian Steiner · New York, NYDirectorJukka Heikka · Dallas, TXExecLynne R. Rollins · San Diego, CAExecKimberly Zaccagnino · New York, NYDirectorIvan Koon · Dallas, TXExec · DirectorMaia Heymann · Dallas, TXDirectorWilliam R. Harrington, Md, Mba · San Diego, CADirectorPatrick Hardiman · New York, NYDirectorDennis T. Podlesak · San Diego, CADirectorAdam Glick · New York, NYDirectorEdward Martinson · New York, NYDirectorMark Affolter · New York, NYDirectorKeith A. Katkin · San Diego, CADirectorBrent R. Ahrens · San Diego, CADirectorGarret J. Hrncir · Menomonee Falls, WIExec · DirectorDaniel R. Hetu, Md, Mba · San Diego, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗